[Adhesion molecules in systemic scleroderma].

Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: results from the EULAR Scleroderma Trial and Research Group (EUSTAR) database. J Rheumatol (2010) 0.96

[C-reactive protein--marker of inflammation in atherosclerosis (new data)]. Kardiologiia (2002) 0.88

[Investigation of mechanisms of neuro-protective effect of semax in acute period of ischemic stroke]. Zh Nevrol Psikhiatr Im S S Korsakova (1999) 0.87

[Neopterin: new immunological marker of autoimmune rheumatic disease]. Klin Med (Mosk) (2000) 0.83

Lack of association between three vascular endothelial growth factor gene polymorphisms and systemic sclerosis: results from a multicenter EUSTAR study of European Caucasian patients. Ann Rheum Dis (2006) 0.83

[Evaluation of methotrexate effect on the acute-phase response in rheumatoid arthritis after 12-week treatment]. Klin Med (Mosk) (2014) 0.82

[Anti-phosphatidylethanolamine antibodies in patients with Sneddon's syndrome]. Klin Med (Mosk) (2005) 0.82

[Cardiolipin antibodies in acute rheumatic fever]. Klin Med (Mosk) (1992) 0.82

[The efficiency and safety of adalimumab treatment in patients with active rheumatoid arthritis unresponsive to standard therapy: Russian national study results]. Ter Arkh (2012) 0.81

[Cardiolipin antibodies in patients with myocardial infarction and unstable angina pectoris]. Kardiologiia (1992) 0.80

[Cardiac rhythm and conduction disorders in polymyositis and dermatomyositis]. Klin Med (Mosk) (1998) 0.80

C3a and C5a anaphylatoxins bind to heparin-based sorbent in low density lipoprotein apheresis: in vitro and in vivo investigations. Artif Organs (1992) 0.80

[Prevalence of mental disorders in SLE patients: correlations with the disease activity and comorbid chronic conditions]. Ter Arkh (2009) 0.80

[Effect of small-dose glucocorticoids on the course of early rheumatic arthritis]. Klin Med (Mosk) (2004) 0.79

[Structum (chondroitin sulfate)--a new agent for the treatment of osteoarthrosis]. Ter Arkh (1999) 0.78

[Tramadol in the vascular pains of patients with systemic scleroderma and other rheumatic diseases]. Ter Arkh (1994) 0.78

[Serum neopterin in hepatitis B]. Klin Med (Mosk) (1992) 0.78

[New approaches to pharmacotherapy for rheumatoid arthritis: perspective for use of tocilizumab (monoclonal antibodies to interleukin-6 receptor)]. Ter Arkh (2010) 0.78

[Cardiovascular diseases in rheumatoid arthritis]. Ter Arkh (2007) 0.77

[Serum nitrates in patients with systemic lupus erythematosus and antiphospholipid syndrome]. Ter Arkh (2004) 0.77

[Efficacy of colloid bismuth subcitrate (De-Nol) in gastropathies induced by nonsteroid anti-inflammatory drugs: an open controlled 4-week trial]. Ter Arkh (2005) 0.77

[Relationship of the clinical efficiency of tocilizumab therapy to the serum level of matrix metalloproteinase-3 in patients with rheumatoid arthritis]. Ter Arkh (2013) 0.77

[The magnitude of fatigue and its association with depression, pain, and inflammatory activity in rheumatoid arthritis]. Ter Arkh (2013) 0.77

[The von Willebrand factor antigen in patients with rheumatoid arthritis: a method for its determination and the clinical significance]. Ter Arkh (1993) 0.77

[Role of antiphospholipid antibodies in occlusion of retinal vessels in various vascular eye diseases]. Vestn Oftalmol (2002) 0.77

[Clinical associations of C-reactive protein in systemic sclerosis]. Ter Arkh (2006) 0.77

[Clinical implication of assessment of heart rate variability in patients with psoriatic arthritis]. Ter Arkh (2009) 0.77

[The importance of cytokine profile characteristics for evaluating the therapeutic effectiveness of monoclonal antibodies against IL-6 receptors in patients with rheumatoid arthritis]. Klin Med (Mosk) (2014) 0.77

[Prospects for the assessment of cardiac rhythm variability in patients with rheumatoid arthritis and systemic lupus erythematosus]. Vestn Ross Akad Med Nauk (2010) 0.77

[Cardiological aspects of the antiphospholipid syndrome. Part I. Valvular lesions in the primary and secondary antiphospholipid syndrome and systemic lupus erythematosus]. Kardiologiia (2002) 0.77

[The functional activity and count of the natural killer cells in patients with recently diagnosed diabetes mellitus types I and II]. Ter Arkh (1989) 0.76

[Soluble CD40 ligand in systemic lupus erythematosus and antiphospholipid syndrome]. Ter Arkh (2006) 0.76

[Cognitive impairment and anxiety-depressive disorders in patients with rheumatoid arthritis]. Zh Nevrol Psikhiatr Im S S Korsakova (2012) 0.76

[Subclinical and clinical manifestations of atherosclerosis in antiphospholipid syndrome]. Ter Arkh (2008) 0.76

[Soluble receptors of TNF-alpha in rheumatoid arthritis]. Klin Med (Mosk) (2001) 0.76

[Sneddon's syndrome and the primary antiphospholipid syndrome]. Ter Arkh (1993) 0.76

[Antibodies to beta2-glycoprotein I in systemic lupus erythematosus: new laboratory marker of antiphospholipid syndrome]. Klin Med (Mosk) (1998) 0.76

[Autoantibodies Against beta(1)-Adrenoreceptors in Patients With Cardiac Rhythm Disorders. Prevalence and Possible Role in Development of Arrhythmia]. Kardiologiia (2004) 0.76

[Obliterating bronchiolitis induced by D-penicillamine in the female patient with systemic scleroderma]. Ter Arkh (2004) 0.76

Sneddon's syndrome: cardiac pathology and antiphospholipid antibodies. Clin Exp Rheumatol (1991) 0.76

[The clinical significance of neopterin in human diseases]. Ter Arkh (1993) 0.76

[Soluble adhesion molecules (P-selectin, ICAM-1 and ICAM-3) in rheumatoid arthritis]. Ter Arkh (1999) 0.76

Anticardiolipin antibodies in Sneddon's syndrome. Neurology (1990) 0.76

[Soluble receptors of TNF-alpha with molecular mass 55 kDa in rheumatoid arthritis: clinical role]. Klin Med (Mosk) (2003) 0.76

[Differential diagnosis of Wegener's granulomatosis and extranodal NK/T-cell lymphoma, nasal type]. Ter Arkh (2012) 0.76

[Pharmacotherapy of rheumatoid arthritis: the 21st century]. Klin Med (Mosk) (2005) 0.75

[Combined medication ARTRA in the treatment of osteoarthrosis]. Ter Arkh (2005) 0.75

[The renin-angiotensin-aldosterone system and arterial hypertension in patients with rheumatoid arthritis]. Klin Med (Mosk) (1991) 0.75

[Circulating immune complexes and cellular cytotoxic reactions in Sjögren's syndrome]. Ter Arkh (1988) 0.75

[Interrelation of autoimmune and immune complex pathology: the current status of the problem]. Ter Arkh (1984) 0.75

[Autoimmune component in chronic active hepatitis and its connection with isolation of the hepatitis B surface antigen]. Ter Arkh (1977) 0.75

[Antibody-dependent and natural cellular cytotoxic reactions in rheumatic diseases]. Ter Arkh (1984) 0.75

[Anti-cardiolipin antibodies: a method of their detection and clinical significance]. Klin Med (Mosk) (1987) 0.75

[Natural cytotoxicity in systemic lupus erythematosus patients]. Ter Arkh (1984) 0.75

[Circulating immune complexes in patients with vasculitis of the skin]. Vestn Dermatol Venerol (1983) 0.75

[Laser nephelometry in clinical immunology (review of the literature)]. Lab Delo (1988) 0.75

[Clinico-immunological characteristics of patients with systemic lupus erythematosus and cryoglobulinemia]. Revmatologiia (Mosk) (1991) 0.75

[The antiphospholipid syndrome: clinical and immunological aspects]. Klin Med (Mosk) (1989) 0.75

[Clinico-immunological evaluation by a spectrophotometric method of determining cryoglobulins in rheumatic diseases]. Revmatologiia (Mosk) (1988) 0.75

[Clinical importance of determining circulating immune complexes in patients with gouty arthritis]. Revmatologiia (Mosk) (1989) 0.75

[Antibodies to the myelin major protein in patients with dilated cardiomyopathy. Determination and diagnostic significance]. Lab Delo (1989) 0.75

[The correlation of the indices of humoral immunity and of the activity of the renin-angiotensin-aldosterone system in hypertensive patients]. Ter Arkh (1991) 0.75

[Viral infection and immune mechanisms of the pathogenesis of diabetes mellitus type 1]. Ter Arkh (1989) 0.75

[Immunoregulatory disorders and activation of the immune system in dilated cardiomyopathy]. Ter Arkh (1988) 0.75

[Sedimentation of circulating immune complexes with polyethylene glycol combined with immunoenzyme method--a new approach to analysis of circulating immune complexes in the sera of patients with rheumatic diseases]. Revmatologiia (Mosk) (1991) 0.75

[Clinico-diagnostic aspects of rheumatic polymyalgia (literature review and case reports)]. Ter Arkh (1981) 0.75

[Clinical assessment of circulating immune complexes in infectious endocarditis]. Klin Med (Mosk) (1984) 0.75

Ex vivo removal of IgE in atopic asthma by extracorporeal plasmoimmunoadsorption (EPIA): development of a clinical adsorbent. Int J Artif Organs (1991) 0.75

[Activation of the complement system in dilated cardiomyopathy]. Ter Arkh (1989) 0.75

[Immunoglobulin E in systemic lupus erythematosus]. Klin Med (Mosk) (1989) 0.75

[Cryoglobulinemia in rheumatic diseases]. Klin Med (Mosk) (1991) 0.75

[Circulating immune complexes in rheumatic diseases]. Ter Arkh (1981) 0.75

[Diagnosis of systemic vasculitis in rheumatoid arthritis patients (a clinico-immunomorphological study)]. Revmatologiia (Mosk) (1985) 0.75

[The clinical importance of the dynamic determination of the serum neopterin level in patients with dilated cardiomyopathy]. Ter Arkh (1991) 0.75

[The dynamics of the concentrations of immunoglobulins and circulating immune complexes during low-density lipoprotein apheresis in patients with hereditary hypercholesterolemia]. Ter Arkh (1991) 0.75

[Diagnosis of liver disorder in amyloidosis]. Ter Arkh (1975) 0.75

[Hyperuricemia, gout and gout-induced nephropathy]. Ter Arkh (1980) 0.75

[Clinico-pathogenetic factors in the development of immune complex disease]. Ter Arkh (1980) 0.75

[Antibodies reacting with the antigens of the human immunodeficiency virus in systemic lupus erythematosus: false positive results or a sign of viral infection]. Vopr Virusol (1989) 0.75

[Objective assessment of serological methods in the diagnosis of systemic lupus erythematosus]. Ter Arkh (1987) 0.75

[Cryoglobulinemia and fibronectin in systemic lupus erythematosus]. Ter Arkh (1991) 0.75

[Effect of the synthetic endogenous opioid analog dalargin on the natural cytotoxicity of human lymphocytes]. Biull Eksp Biol Med (1988) 0.75

[Gerontological and geriatric problems of nephrology]. Ter Arkh (1981) 0.75

[Interleukin 1 and its role in human pathology]. Ter Arkh (1987) 0.75

[Antimitochrondrial antibodies in chronic liver diseases]. Sov Med (1976) 0.75

[Disorders of humoral immunity in hypertension]. Klin Med (Mosk) (1989) 0.75

[Sneddon syndrome (its association with anti-cardiolipin antibodies)]. Klin Med (Mosk) (1988) 0.75

[Current approaches to immunological diagnosis of autoimmune and immune complex diseases]. Ter Arkh (1988) 0.75

[Modulation of the proliferative response of lymphocytes with a new enkephalin analog--dalargin]. Ter Arkh (1984) 0.75

[The role of anti-phospholipid antibodies in the development of thrombotic complications and in obstetrical pathology]. Klin Med (Mosk) (1989) 0.75

[Disorders of humoral immunity in nonspecific aortoarteritis]. Klin Med (Mosk) (1991) 0.75

[The cellular immunity indices in diabetic nephropathy]. Ter Arkh (1991) 0.75

[Antibodies reacting with the antigens of the human immunodeficiency virus in systemic lupus erythematosus]. Ter Arkh (1987) 0.75

[Hyperproduction of immunoglobulin E in occlusive diseases of the peripheral arteries]. Klin Med (Mosk) (1991) 0.75

[Clinical value of determining the levels of lupus anticoagulant and anti-cardiolipin antibodies]. Ter Arkh (1988) 0.75

[Clinico-immunological characteristics of systemic lupus erythematosus with Raynaud and Sjögren's syndromes (report I)]. Ter Arkh (1985) 0.75

[Effects of atrial natriuretic factor on proliferative response and natural cytotoxicity of human lymphocytes]. Biull Eksp Biol Med (1991) 0.75

[Endothelin in arterial hypertension]. Ter Arkh (1991) 0.75

[Natural cytotoxicity in Sjögren's syndrome]. Ter Arkh (1984) 0.75

[Possibilities for using the analytical ultracentrifugation method for determining circulating immune complexes in rheumatic diseases]. Ter Arkh (1984) 0.75